Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease

Front Neurol. 2023 Jun 15:14:1227084. doi: 10.3389/fneur.2023.1227084. eCollection 2023.

Gabriel Torrealba-Acosta^#^{1

2}, Eric Yu^#^{3

4}, Tanya Lobo-Prada^{2

5}, Javier Ruíz-Martínez^{6

7

8}, Ana Gorostidi-Pagola^{7

8

9}, Ziv Gan-Or^{3

4

10}, Kenneth Carazo-Céspedes¹¹, Jean-François Trempe¹², Ignacio F Mata¹³, Jaime Fornaguera-Trías^{2

5}

¹ Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
² Neurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica.
³ Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
⁴ Department of Human Genetics, McGill University, Montreal, QC, Canada.
⁵ Department of Biochemistry, Medicine School, Universidad de Costa Rica, San José, Costa Rica.
⁶ Group of Neurodegenerative Diseases, Biodonostia Health Research Institute, San Sebastian, Spain.
⁷ CIBERNED, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
⁸ Movement Disorders Unit, Neurology Department, Donostialdea Integrated Health Organisation, Osakidetza Basque Health Service, San Sebastian, Spain.
⁹ Genomic Platform, Biodonostia Health Research Institute, San Sebastian, Spain.
¹⁰ Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
¹¹ Department of Neurology, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, San José, Costa Rica.
¹² Department of Pharmacology and Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, QC, Canada.
¹³ Cleveland Clinic Foundation, Genomic Medicine, Lerner Research Institute, Cleveland, OH, United States.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fneur.2021.656342.].

Keywords: Costa Rica; Latin America; Parkinson's disease; genotype; phenotype.